期刊文献+

蟾蜍皮肤提取物QUB2419的降压作用及机制初探

Antihypertensive effect of QUB2419,an extract from toad skin,and the possible mechanism
原文传递
导出
摘要 目的:考察QUB2419对高血压大鼠的降压作用及其作用机制。方法:采用自发性高血压大鼠(SHR)和肾性高血压大鼠(RHR),尾静脉注射给药,观察给药前后血压的变化;采用血管平滑肌细胞(VSMCs),考察QUB2419对血小板衍生生长因子-BB(PDGF-BB)诱导VSMCs增殖的抑制作用;采用人脐静脉内皮细胞(HUVECs),Western Blot方法考察QUB2419对细胞中内皮型一氧化氮合酶(eNOS)、腺苷酸活化蛋白激酶(AMPK)、蛋白激酶B (AKT)蛋白磷酸化的影响。结果:QUB2419给药后2 min即显著降低SHR和RHR的血压,且降压作用呈剂量依赖性。QUB2419能够显著抑制PDGF-BB诱导的VSMCs的增殖。QUB2419能够显著增加HUVECs中p-eNOS,p-AMPK和p-AKT的蛋白表达。结论:QUB2419可显著降低高血压大鼠的血压,并抑制血管平滑肌细胞的增殖,其降压机制可能与增加HUVECs中p-eNOS,p-AMPK和p-AKT的蛋白表达相关。 Objective: To investigate the antihypertensive effect of QUB2419 in hypertensive rats and the possible mechanism. Methods: Spontaneous hypertensive rats( SHR) and renal hypertensive rats( RHR) were used. QUB2419 was injected via caudal vein,and the changes in blood pressure after dosing were observed. In vascular smooth muscle cells( VSMCs),the inhibition effect of QUB2419 on proliferation induced by plateletderived growth factor-BB( PDGF-BB) was determined. The expression of phosphorylated endothelial nitric oxide synthase( p-NOS),phosphorylated AMP-activated protein kinase( p-AMPK),and phosphorylated protein kinase B( p-AKT) in human umbilical vein endothelial cells( HUVECs) were detected by Western Blot assay. Results:Two minutes after administration,QUB2419 reduced the blood pressure in SHR and RHR in a dose-dependent manner. QUB2419 inhibited PDGF-BB-induced proliferation in VSMCs,and increased the phosphorylation of e NOS,AMPK and AKT in HUVECs. Conclusion: QUB2419 reduces the blood pressure in hypertensive rats,and inhibits proliferation of HUVECs. The antihypertensive mechanism of QUB2419 may relate to increasing p-eNOS,p-AMPK and p-AKT in vascular cells.
作者 刘瑞民 王海慧 施维 徐霁雪 徐丽诗 于扬 徐成 LIU Rui-min;WANG Hai-hui;SHI Wei;XU Ji-xue;XU Li-shi;YU Yang;XU Cheng(College of Life Science and Biological Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China;School of Medical Devices,Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2019年第3期341-345,共5页 Chinese Journal of New Drugs
关键词 QUB2419 细胞增殖 高血压 p-eNOS p-AMPK P-AKT QUB2419 cell proliferation hypertension p-eNOS p-AMPK p-AKT
  • 相关文献

参考文献6

二级参考文献46

  • 1刘新林,李玉明.缓激肽β受体与高血压研究进展[J].武警医学,2006,17(3):219-221. 被引量:3
  • 2曹永孝,李洁,刘浩,罗国刚.高血压大鼠和高血压患者血管平滑肌α肾上腺素受体的反应性增强作用[J].药学学报,2006,41(10):973-977. 被引量:8
  • 3徐叔云 卞如廉 等.药理学实验方法(第二版)[M].北京:人民卫生出版社,1991.921.
  • 4顾德官 顾天华 等.试验性高血压大鼠的血压观察[J].上海第二医学院学报,1985,2:102-102.
  • 5郭学青,张梦翔,高飞,高云颂,李春英.原发性高血压与内皮素升高关系的研究[J].华北国防医药,2007,19(4):9-10. 被引量:4
  • 6王海燕.肾脏病学[M].北京:人民卫生出版社,2001.1442-1446.
  • 7Uta Kossatz Nisar P Malek.p27: tumor suppressor and oncogene ...?[J].Cell Research,2007,17(10):832-833. 被引量:1
  • 8Morand-Contant M, Anand-Srivastava MB, Couture R. Kinin B1 receptorupregulation by angiotensin Ⅱ and endothelin-1 in rat vascular smooth muscle cells:Receptors and mechanisms[ J]. Am J Physiol Heart CircPhysiol, 2010,299 ( 5 ) : H1625-1632. DOI:10, 1152/ajpheart. 00735. 2009.
  • 9Kuhr F,Iowry J, Zhang Y, et al. Differential regulation of induc- ible and endothelial nitric oxide synthase by kinin B1 and B2 re- ceptors[ J ]. Neuropeptides, 2010,44 ( 2 ) : 145-154. DOI: 10. lO16/j, npep. 2009.12. 004.
  • 10Kakoki M, Smithies O. The kallikrein-kinin system in health and in diseases of the kidney[ Jl. Kidney Int,2009,75 (10) :1019- 1030. DOI : 10. 1038/ki. 2008. 647.

共引文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部